Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)

V. Patel; M. J. W. Mcphail; A. Zamalloa; S. Stoy; G. M. Vijay; X. Huang; G. Rogers; J. Choo; L. Edwards; E. Gray; C. Woodhouse; S. Gencer; M. Coen; J. Wendon; K. Bruce; D. Shawcross

Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)

V. Patel, M. J. W. Mcphail, A. Zamalloa, S. Stoy, G. M. Vijay, X. Huang, G. Rogers, J. Choo, L. Edwards, E. Gray, C. Woodhouse, S. Gencer, M. Coen, J. Wendon, K. Bruce, D. Shawcross

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S107-S108
Journal	Journal of Hepatology
Volume	68
Publication status	Published - Apr 2018

Cite this

Patel, V., Mcphail, M. J. W., Zamalloa, A., Stoy, S., Vijay, G. M., Huang, X., Rogers, G., Choo, J., Edwards, L., Gray, E., Woodhouse, C., Gencer, S., Coen, M., Wendon, J., Bruce, K., & Shawcross, D. (2018). Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial). Journal of Hepatology, 68, S107-S108.

@article{7af7faf62c2a4475bb2cd9004e939b04,

title = "Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)",

author = "V. Patel and Mcphail, {M. J. W.} and A. Zamalloa and S. Stoy and Vijay, {G. M.} and X. Huang and G. Rogers and J. Choo and L. Edwards and E. Gray and C. Woodhouse and S. Gencer and M. Coen and J. Wendon and K. Bruce and D. Shawcross",

year = "2018",

month = apr,

language = "English",

volume = "68",

pages = "S107--S108",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "ELSEVIER SCIENCE BV",

}

Patel, V , Mcphail, MJW, Zamalloa, A, Stoy, S, Vijay, GM, Huang, X, Rogers, G, Choo, J, Edwards, L , Gray, E , Woodhouse, C, Gencer, S, Coen, M, Wendon, J , Bruce, K & Shawcross, D 2018, 'Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)', Journal of Hepatology, vol. 68, pp. S107-S108.

Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial). / Patel, V.; Mcphail, M. J. W.; Zamalloa, A. et al.
In: Journal of Hepatology, Vol. 68, 04.2018, p. S107-S108.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)

AU - Patel, V.

AU - Mcphail, M. J. W.

AU - Zamalloa, A.

AU - Stoy, S.

AU - Vijay, G. M.

AU - Huang, X.

AU - Rogers, G.

AU - Choo, J.

AU - Edwards, L.

AU - Gray, E.

AU - Woodhouse, C.

AU - Gencer, S.

AU - Coen, M.

AU - Wendon, J.

AU - Bruce, K.

AU - Shawcross, D.

PY - 2018/4

Y1 - 2018/4

M3 - Meeting Abstract

SN - 0168-8278

VL - 68

SP - S107-S108

JO - Journal of Hepatology

JF - Journal of Hepatology

ER -